| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 26.1% | HC Wainwright & Co. | $150 → $165 | Maintains | Buy |
| 06/05/2023 | 14.64% | HC Wainwright & Co. | $140 → $150 | Maintains | Buy |
| 02/27/2023 | 6.99% | HC Wainwright & Co. | $152 → $140 | Maintains | Buy |
| 11/07/2022 | 16.16% | HC Wainwright & Co. | $164 → $152 | Maintains | Buy |
| 08/22/2022 | 25.33% | HC Wainwright & Co. | $152 → $164 | Maintains | Buy |
| 05/02/2022 | 16.16% | HC Wainwright & Co. | $155 → $152 | Maintains | Buy |
| 03/08/2022 | 18.46% | HC Wainwright & Co. | $170 → $155 | Maintains | Buy |
| 02/22/2022 | 33.74% | Sidoti & Co. | → $175 | Upgrades | Neutral → Buy |
| 01/10/2022 | 29.92% | HC Wainwright & Co. | $160 → $170 | Maintains | Buy |
| 11/29/2021 | 33.74% | Sidoti & Co. | → $175 | Downgrades | Buy → Neutral |
| 08/02/2021 | 10.81% | Stephens & Co. | $140 → $145 | Downgrades | Overweight → Equal-Weight |
| 08/02/2021 | 22.28% | HC Wainwright & Co. | $145 → $160 | Upgrades | → Buy |
| 02/22/2021 | 6.99% | Stephens & Co. | $100 → $140 | Upgrades | Equal-Weight → Overweight |
| 02/22/2021 | 10.81% | HC Wainwright & Co. | $126 → $145 | Maintains | Buy |
| 08/04/2020 | -3.71% | HC Wainwright & Co. | $104 → $126 | Maintains | Buy |
| 07/10/2020 | -23.58% | Stephens & Co. | → $100 | Initiates Coverage On | → Equal-Weight |
| 05/04/2020 | -20.52% | HC Wainwright & Co. | $116 → $104 | Maintains | Buy |
| 02/24/2020 | -11.35% | HC Wainwright & Co. | $122 → $116 | Maintains | Buy |
| 05/06/2019 | -23.58% | Pivotal Research | → $100 | Downgrades | Buy → Hold |
| 10/16/2018 | -2.94% | Sidoti & Co. | $127 → $127 | Upgrades | Neutral → Buy |
| 09/25/2018 | 6.99% | HC Wainwright & Co. | → $140 | Initiates Coverage On | → Buy |
What is the target price for Balchem (BCPC)?
The latest price target for Balchem (NASDAQ: BCPC) was reported by HC Wainwright & Co. on July 31, 2023. The analyst firm set a price target for $165.00 expecting BCPC to rise to within 12 months (a possible 26.10% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Balchem (BCPC)?
The latest analyst rating for Balchem (NASDAQ: BCPC) was provided by HC Wainwright & Co., and Balchem maintained their buy rating.
When is the next analyst rating going to be posted or updated for Balchem (BCPC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Balchem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Balchem was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
Is the Analyst Rating Balchem (BCPC) correct?
While ratings are subjective and will change, the latest Balchem (BCPC) rating was a maintained with a price target of $150.00 to $165.00. The current price Balchem (BCPC) is trading at is $130.85, which is out of the analyst's predicted range.